Alimera sciences reports first quarter 2024 results

Atlanta, may 14, 2024 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the first quarter of 2024. alimera will host a conference call today at 9:00 a.m. edt to discuss these results.
ALIM Ratings Summary
ALIM Quant Ranking